Prudential Financial
SLXP

Prudential Financial’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Prudential Financial’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-45,166
Closed -$7.8M – 2318
2015
Q1 		$7.8M Sell
45,166
-550
-1% -$80.7K 0.01% 939
2014
Q4 		$5.25M Buy
45,716
+4,820
+12% +$584K 0.01% 976
2014
Q3 		$6.39M Sell
40,896
-15,015
-27% -$2.18M 0.01% 849
2014
Q2 		$6.9M Sell
55,911
-212,795
-79% -$23.5M 0.01% 869
2014
Q1 		$27.8M Buy
268,706
+228,500
+568% +$23.4M 0.05% 365
2013
Q4 		$3.62M Sell
40,206
-470
-1% -$37.5K 0.01% 1145
2013
Q3 		$2.72M Sell
40,676
-82,431
-67% -$5.68M 0.01% 1240
2013
Q2 		$8.14M Buy
+123,107
New +$7.04M 0.02% 709

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Prudential Financial's SLXP Position: Q2 2015 in Review

Prudential Financial sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 45,166 shares — an estimated $7.8M sold.

Prudential Financial first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $27.8M in Q1 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Prudential Financial reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Prudential Financial sold 45,166 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $7.8M.
  • Prudential Financial first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Prudential Financial's SALIX PHARMACEUTICALS LTD DEL position peaked at $27.8M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Prudential Financial's 13F filing for Q2 2015, filed 6 Aug 2015.